Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model | Zendy

George G. Zhanel | Zendy; C. Yachison | Zendy; Kimberly A. Nichol | Zendy; Heather J. Adam | Zendy; Ayman Noreddin | Zendy; D. J. Hoban | Zendy; James A. Karlowsky | Zendy

Open Access

Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model

Author(s) -

George G. Zhanel,

C. Yachison,

Kimberly A. Nichol,

Heather J. Adam,

Ayman Noreddin,

D. J. Hoban,

James A. Karlowsky

Publication year - 2012

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dks113

Subject(s) - streptococcus pneumoniae , penicillin , microbiology and biotechnology , cephalosporin , medicine , pharmacodynamics , antibiotics , in vitro , antibacterial agent , chemistry , pharmacology , pharmacokinetics , biology , biochemistry

This study assessed the pharmacodynamics of ceftaroline against penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research